Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC
Background: HOIP is the catalytic subunit of the linear ubiquitination chain assembly complex (LUBAC) that is essential for NF-κB signaling and thus proper innate and adaptive immunity. To date only one patient with HOIP deficiency has been reported with clinical characteristics that include autoinf...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00479/full |
id |
doaj-8af4a14f355248ea9daee0527dcd8fbe |
---|---|
record_format |
Article |
spelling |
doaj-8af4a14f355248ea9daee0527dcd8fbe2020-11-24T21:20:53ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-03-011010.3389/fimmu.2019.00479432364Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBACHirotsugu Oda0David B. Beck1Hye Sun Kuehn2Natalia Sampaio Moura3Patrycja Hoffmann4Maria Ibarra5Jennifer Stoddard6Wanxia Li Tsai7Gustavo Gutierrez-Cruz8Massimo Gadina9Sergio D. Rosenzweig10Daniel L. Kastner11Luigi D. Notarangelo12Ivona Aksentijevich13Inflammatory Disease Section, National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, United StatesInflammatory Disease Section, National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, United StatesDepartment of Laboratory Medicine, NIH Clinical Center (CC), Bethesda, MD, United StatesInflammatory Disease Section, National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, United StatesInflammatory Disease Section, National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, United StatesDivision of Pediatric Rheumatology, Children's Mercy Hospital, Kansas City, MO, United StatesDepartment of Laboratory Medicine, NIH Clinical Center (CC), Bethesda, MD, United StatesOffice of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United StatesOffice of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United StatesOffice of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United StatesDepartment of Laboratory Medicine, NIH Clinical Center (CC), Bethesda, MD, United StatesInflammatory Disease Section, National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, United StatesLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United StatesInflammatory Disease Section, National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, United StatesBackground: HOIP is the catalytic subunit of the linear ubiquitination chain assembly complex (LUBAC) that is essential for NF-κB signaling and thus proper innate and adaptive immunity. To date only one patient with HOIP deficiency has been reported with clinical characteristics that include autoinflammation, immunodeficiency, amylopectinosis, and systemic lymphangiectasia.Case: We sought to identify a genetic cause of a disease for an 8 year-old girl who presented with early-onset immune deficiency and autoinflammation.Methods: Targeted next generation sequencing of 352 immune-related genes was performed. Functional studies included transcriptome analysis, cytokine profiling, and protein analysis in patients' primary cells.Results: We identified biallelic variants in close proximity to splice sites (c.1197G>C and c.1737+3A>G) in the RNF31 gene. RNA extracted from patient cells showed alternatively spliced transcripts not present in control cells. Protein expression of HOIP and LUBAC was reduced in primary cells as shown by western blotting. Patient-derived fibroblasts demonstrated attenuated IL-6 production, while PBMCs showed higher TNF production after stimulation with proinflammatory cytokines. RNA sequencing of whole blood RNA and PBMCs demonstrated a marked transcriptome wide change including differential expression of type I interferon regulated genes.Conclusion: We report the second case of HOIP deficiency with novel compound heterozygous mutations in RNF31 and distinct clinical and molecular features. Our results expand on the clinical spectrum of HOIP deficiency and molecular signatures associated with LUBAC deficiency.https://www.frontiersin.org/article/10.3389/fimmu.2019.00479/fullLUBACHOIPHOIL1SHARPINprimary immunodeficiencyautoinflammation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hirotsugu Oda David B. Beck Hye Sun Kuehn Natalia Sampaio Moura Patrycja Hoffmann Maria Ibarra Jennifer Stoddard Wanxia Li Tsai Gustavo Gutierrez-Cruz Massimo Gadina Sergio D. Rosenzweig Daniel L. Kastner Luigi D. Notarangelo Ivona Aksentijevich |
spellingShingle |
Hirotsugu Oda David B. Beck Hye Sun Kuehn Natalia Sampaio Moura Patrycja Hoffmann Maria Ibarra Jennifer Stoddard Wanxia Li Tsai Gustavo Gutierrez-Cruz Massimo Gadina Sergio D. Rosenzweig Daniel L. Kastner Luigi D. Notarangelo Ivona Aksentijevich Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC Frontiers in Immunology LUBAC HOIP HOIL1 SHARPIN primary immunodeficiency autoinflammation |
author_facet |
Hirotsugu Oda David B. Beck Hye Sun Kuehn Natalia Sampaio Moura Patrycja Hoffmann Maria Ibarra Jennifer Stoddard Wanxia Li Tsai Gustavo Gutierrez-Cruz Massimo Gadina Sergio D. Rosenzweig Daniel L. Kastner Luigi D. Notarangelo Ivona Aksentijevich |
author_sort |
Hirotsugu Oda |
title |
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC |
title_short |
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC |
title_full |
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC |
title_fullStr |
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC |
title_full_unstemmed |
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC |
title_sort |
second case of hoip deficiency expands clinical features and defines inflammatory transcriptome regulated by lubac |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2019-03-01 |
description |
Background: HOIP is the catalytic subunit of the linear ubiquitination chain assembly complex (LUBAC) that is essential for NF-κB signaling and thus proper innate and adaptive immunity. To date only one patient with HOIP deficiency has been reported with clinical characteristics that include autoinflammation, immunodeficiency, amylopectinosis, and systemic lymphangiectasia.Case: We sought to identify a genetic cause of a disease for an 8 year-old girl who presented with early-onset immune deficiency and autoinflammation.Methods: Targeted next generation sequencing of 352 immune-related genes was performed. Functional studies included transcriptome analysis, cytokine profiling, and protein analysis in patients' primary cells.Results: We identified biallelic variants in close proximity to splice sites (c.1197G>C and c.1737+3A>G) in the RNF31 gene. RNA extracted from patient cells showed alternatively spliced transcripts not present in control cells. Protein expression of HOIP and LUBAC was reduced in primary cells as shown by western blotting. Patient-derived fibroblasts demonstrated attenuated IL-6 production, while PBMCs showed higher TNF production after stimulation with proinflammatory cytokines. RNA sequencing of whole blood RNA and PBMCs demonstrated a marked transcriptome wide change including differential expression of type I interferon regulated genes.Conclusion: We report the second case of HOIP deficiency with novel compound heterozygous mutations in RNF31 and distinct clinical and molecular features. Our results expand on the clinical spectrum of HOIP deficiency and molecular signatures associated with LUBAC deficiency. |
topic |
LUBAC HOIP HOIL1 SHARPIN primary immunodeficiency autoinflammation |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.00479/full |
work_keys_str_mv |
AT hirotsuguoda secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT davidbbeck secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT hyesunkuehn secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT nataliasampaiomoura secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT patrycjahoffmann secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT mariaibarra secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT jenniferstoddard secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT wanxialitsai secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT gustavogutierrezcruz secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT massimogadina secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT sergiodrosenzweig secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT daniellkastner secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT luigidnotarangelo secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac AT ivonaaksentijevich secondcaseofhoipdeficiencyexpandsclinicalfeaturesanddefinesinflammatorytranscriptomeregulatedbylubac |
_version_ |
1726002385452531712 |